Ulcerative Colitis

This is a study to evaluate the safety and efficacy of a twice daily medication compared to a marketed medication for ulcerative colitis.

Those who qualify for this trail should be at least 18 years old who have had mild-to-moderate active flare sometime during the four weeks preceding the screening visit and have taken corticosteroids or immune-suppressing drugs within the last 30 days.

The research site is in Mineola, N.Y.

More information

Please see http://www.centerwatch.com/patient/studies/cat152.html.

-----

Asthma

This is a research study for adults and adolescents with mild-to-moderate persistent asthma.

The purpose of this study is to obtain information about a research drug by determining the dose that will best treat asthma and to collect safety information on the medication.

Candidates may be included who are 12 or older and have had a history of persistent bronchial asthma for at least six months prior to screening.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat16.html

-----

Interstitial Cystitis

This study is designed to evaluate the efficacy and safety of an investigational oral medication to treat interstitial cystitis/painful bladder syndrome.

Volunteers 18 or older who have had a diagnosis of painful bladder syndrome/interstitial cystitis with current symptoms for at least 12 consecutive weeks may be eligible to participate.

However, patients with a diagnosis suggestive of chronic, severe painful bladder syndrome/interstitial cystitis with symptoms for six years or more or with urge incontinence or OAB will not be included in this trial.

The research site is in Aventura, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat89.html.